.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Teva
Cipla
Express Scripts
Queensland Health
Cerilliant
Federal Trade Commission
Healthtrust
Farmers Insurance
McKinsey

Generated: December 18, 2017

DrugPatentWatch Database Preview

AXID Drug Profile

« Back to Dashboard

Which patents cover Axid, and what generic alternatives are available?

Axid is a drug marketed by Smithkline Beecham, Braintree, and Pfizer. and is included in three NDAs. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has two patent family members in two countries.

The generic ingredient in AXID is nizatidine. There are seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the nizatidine profile page.
Drug patent expirations by year for AXID

Medical Subject Heading (MeSH) Categories for AXID

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Smithkline BeechamAXIDnizatidineCAPSULE;ORAL019508-001Apr 12, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
PfizerAXID ARnizatidineTABLET;ORAL020555-001May 9, 1996OTCYesYes► Subscribe► Subscribe► Subscribe
Smithkline BeechamAXIDnizatidineCAPSULE;ORAL019508-002Apr 12, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
BraintreeAXIDnizatidineSOLUTION;ORAL021494-001May 25, 2004DISCNYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: AXID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline BeechamAXIDnizatidineCAPSULE;ORAL019508-002Apr 12, 1988► Subscribe► Subscribe
Smithkline BeechamAXIDnizatidineCAPSULE;ORAL019508-001Apr 12, 1988► Subscribe► Subscribe
Smithkline BeechamAXIDnizatidineCAPSULE;ORAL019508-002Apr 12, 1988► Subscribe► Subscribe
Smithkline BeechamAXIDnizatidineCAPSULE;ORAL019508-002Apr 12, 1988► Subscribe► Subscribe
Smithkline BeechamAXIDnizatidineCAPSULE;ORAL019508-001Apr 12, 1988► Subscribe► Subscribe
Smithkline BeechamAXIDnizatidineCAPSULE;ORAL019508-001Apr 12, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for AXID

Drugname Dosage Strength RLD Submissiondate
nizatidineOral Solution15 mg/mLAxid5/14/2008

International Patent Family for Tradename: AXID

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2004009077► Subscribe
Australia2003247769► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Cantor Fitzgerald
Julphar
Fuji
Cipla
Farmers Insurance
Express Scripts
McKinsey
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot